Depression Study
Advancing Health and Medicine Through Clinical Research Trials
With our latest clinical trials and comprehensive medical research, we aim to help people experiencing major depression by adding a GLP-1 investigational medicine.
What Is the Major Depressive Disorder Study?
To evaluate the efficacy of a new GLP-1 investigative medicine relative to placebo on symptoms of depression in adult participants with major depressive disorder.
Learn more about the Depression study and the GLP-1 add-on investigational medicine to help the symptoms
Depression is a complex mental health condition that can profoundly impact an individual’s emotional, cognitive, and physical well-being. It is characterized by persistent feelings of sadness, hopelessness, and a loss of interest in activities once enjoyed. Depression can lead to a range of symptoms, including fatigue, changes in sleep and appetite, difficulty concentrating, and even thoughts of self-harm. While the causes of depression are multifaceted, it is a treatable condition, and seeking professional help is crucial for managing and overcoming its challenges.
Join Our Major Depression Study!
Are you or a loved one experiencing symptoms related to depression?
At Bradenton Research Center, we are attempting to improve these symptoms. If you are dealing with issues related to depression, this study may be right for you.
Participation in studies is voluntary, and all medical attention, care, and treatment are provided at no additional cost. Contact us today.
Major Depression Study
The primary objective of a depression clinical trial is to evaluate the safety and efficacy of a new GLP-1 treatment or intervention in alleviating the symptoms of depression. Researchers aim to determine whether the investigational therapy can effectively reduce the severity of depressive episodes, improve mood, and enhance the overall quality of life for individuals suffering from depression. By conducting rigorous clinical trials, researchers can gather crucial data to support the development of more effective and evidence-based treatments, ultimately benefiting those affected by this debilitating mental health condition.
- Participants must:
- Be between 18 and 75 years of age
- Have a diagnosis of MDD on a stable dose of medicine for at least 4 weeks
- Been in remission or near remission for < 6 months with residual symptoms
- Be willing to use contraception
Advantages of Participating in the Major Depression Study
Participating in a depression clinical trial can offer several advantages. It provides access to cutting-edge treatments, personalized care, and close monitoring by medical professionals. Additionally, it contributes to advancing research and the development of more effective therapies for depression, ultimately benefiting the broader community.
Access to a research medicine
An MDD expert will provide close attention and supervision
Opportunity to advance MDD treatment
Reimbursement for travel and time spent on research activities
Participate in a study today!
As part of the study, a GLP-1 investigational medicine is being tested to see if it can help symptoms of major depressive disorder. Current investigational drugs and medications help further study MDD, which affects millions of people every year.
You might be eligible for this study if you show signs of MDD and fit the criteria above.
Contact us today.
Address
3924 9th Ave W, Bradenton, FL 34205
Call Us
(941) 708-0005
Email Us
info@bradentonresearch.com